Clinical Trial Update: Oral Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis in Adult Japanese Participants (ELEVATE UC 40 JAPAN) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing oral etrasimod to placebo for moderately to severely active ulcerative colitis in adult Japanese participants has completed with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Etrasimod (etrasimod)

Snippet

Sponsor: Pfizer | Conditions: Ulcerative Colitis | Phase 3 | Status: COMPLETED | Results posted: 2023-10-16